Elevar Therapeutics Names Dr. Jan M. Van Tornout Chief
SALT LAKE CITY, June 28, 2022 (GLOBE NEWSWIRE) -- Elevar Therapeutics, Inc., a fully integrated biopharmaceutical company dedicated to elevating...
Stay updated with breaking news from Van Tornout. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
SALT LAKE CITY, June 28, 2022 (GLOBE NEWSWIRE) -- Elevar Therapeutics, Inc., a fully integrated biopharmaceutical company dedicated to elevating...
– Comprehensive strategic review identified breast cancer as a priority indication for development, a focus on second-line pancreatic cancer, and continuation of trial in high-risk sarcomas– Recently appointed acting Chief Medical Officer and incoming Chief Financial Officer bolster leadership team expertise– Well-c...
Tyme Technologies, Inc. Completes Strategic Review, Announces OASIS Breast Trial with Georgetown University, and Reports Fiscal Year 2021 Financial Results -... | June 10, 2021